Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

1.

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.

Bidard FC, Madic J, Mariani P, Piperno-Neumann S, Rampanou A, Servois V, Cassoux N, Desjardins L, Milder M, Vaucher I, Pierga JY, Lebofsky R, Stern MH, Lantz O.

Int J Cancer. 2014 Mar 1;134(5):1207-13. doi: 10.1002/ijc.28436. Epub 2013 Sep 3.

PMID:
23934701
[PubMed - indexed for MEDLINE]
2.

Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.

Metz CH, Scheulen M, Bornfeld N, Lohmann D, Zeschnigk M.

Cancer Med. 2013 Apr;2(2):208-15. doi: 10.1002/cam4.61. Epub 2013 Feb 14.

PMID:
23634288
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

Madic J, Piperno-Neumann S, Servois V, Rampanou A, Milder M, Trouiller B, Gentien D, Saada S, Assayag F, Thuleau A, Nemati F, Decaudin D, Bidard FC, Desjardins L, Mariani P, Lantz O, Stern MH.

Clin Cancer Res. 2012 Jul 15;18(14):3934-41. doi: 10.1158/1078-0432.CCR-12-0309. Epub 2012 May 29.

PMID:
22645051
[PubMed - indexed for MEDLINE]
Free Article
4.

Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.

Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, Hughes BG, Hicks RJ, Hampton GM, Amler LC, Pirzkall A, Lackner MR.

Clin Cancer Res. 2012 Apr 15;18(8):2391-401. doi: 10.1158/1078-0432.CCR-11-3148. Epub 2012 Apr 5.

PMID:
22492982
[PubMed - indexed for MEDLINE]
Free Article
5.

Mutations in GNA11 in uveal melanoma.

Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian BC.

N Engl J Med. 2010 Dec 2;363(23):2191-9. doi: 10.1056/NEJMoa1000584. Epub 2010 Nov 17.

PMID:
21083380
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.

Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Thiel E, Foerster MH, Keilholz U.

Oncology. 2011;80(1-2):57-62. doi: 10.1159/000328283. Epub 2011 May 31.

PMID:
21625180
[PubMed - indexed for MEDLINE]
7.

Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11.

Koopmans AE, Vaarwater J, Paridaens D, Naus NC, Kilic E, de Klein A; Rotterdam Ocular Melanoma Study group.

Br J Cancer. 2013 Jul 23;109(2):493-6. doi: 10.1038/bjc.2013.299. Epub 2013 Jun 18.

PMID:
23778528
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.

Pinzani P, Mazzini C, Salvianti F, Massi D, Grifoni R, Paoletti C, Ucci F, Molinara E, Orlando C, Pazzagli M, Neri B.

Melanoma Res. 2010 Aug;20(4):303-10. doi: 10.1097/CMR.0b013e32833906e3.

PMID:
20442676
[PubMed - indexed for MEDLINE]
9.

Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.

Abdel-Rahman MH, Cebulla CM, Verma V, Christopher BN, Carson WE 3rd, Olencki T, Davidorf FH.

Exp Eye Res. 2012 Jul;100:26-31. doi: 10.1016/j.exer.2012.04.010. Epub 2012 May 5.

PMID:
22569040
[PubMed - indexed for MEDLINE]
10.

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.

Dono M, Angelini G, Cecconi M, Amaro A, Esposito AI, Mirisola V, Maric I, Lanza F, Nasciuti F, Viaggi S, Gualco M, Bandelloni R, Truini M, Coviello DA, Zupo S, Mosci C, Pfeffer U.

Br J Cancer. 2014 Feb 18;110(4):1058-65. doi: 10.1038/bjc.2013.804. Epub 2014 Jan 14.

PMID:
24423917
[PubMed - indexed for MEDLINE]
11.

Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.

Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Scheibenbogen C, Thiel E, Foerster MH, Keilholz U.

Clin Cancer Res. 2007 Feb 15;13(4):1171-8.

PMID:
17317826
[PubMed - indexed for MEDLINE]
Free Article
12.

Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.

Koyanagi K, Mori T, O'Day SJ, Martinez SR, Wang HJ, Hoon DS.

Cancer Res. 2006 Jun 15;66(12):6111-7.

PMID:
16778184
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.

Khoja L, Lorigan P, Zhou C, Lancashire M, Booth J, Cummings J, Califano R, Clack G, Hughes A, Dive C.

J Invest Dermatol. 2013 Jun;133(6):1582-90. doi: 10.1038/jid.2012.468. Epub 2012 Dec 6.

PMID:
23223143
[PubMed - indexed for MEDLINE]
Free Article
14.

Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.

Ambrosini G, Pratilas CA, Qin LX, Tadi M, Surriga O, Carvajal RD, Schwartz GK.

Clin Cancer Res. 2012 Jul 1;18(13):3552-61. doi: 10.1158/1078-0432.CCR-11-3086. Epub 2012 May 1.

PMID:
22550165
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations.

Mudhar HS, Doherty R, Salawu A, Sisley K, Rennie IG.

Br J Ophthalmol. 2013 Jul;97(7):924-8. doi: 10.1136/bjophthalmol-2013-303291. Epub 2013 May 17.

PMID:
23685997
[PubMed - indexed for MEDLINE]
16.

Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.

Hoshimoto S, Shingai T, Morton DL, Kuo C, Faries MB, Chong K, Elashoff D, Wang HJ, Elashoff RM, Hoon DS.

J Clin Oncol. 2012 Nov 1;30(31):3819-26. doi: 10.1200/JCO.2011.40.0887. Epub 2012 Sep 24.

PMID:
23008288
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.

Pierga JY, Hajage D, Bachelot T, Delaloge S, Brain E, Campone M, Diéras V, Rolland E, Mignot L, Mathiot C, Bidard FC.

Ann Oncol. 2012 Mar;23(3):618-24. doi: 10.1093/annonc/mdr263. Epub 2011 Jun 3.

PMID:
21642515
[PubMed - indexed for MEDLINE]
Free Article
18.

Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.

Tsianakas A, Böhm MR, Getova V, Metze D, Eter N, Spieker T, Bräuninger A, Luger T, Schiller M, Sunderkötter C.

Br J Dermatol. 2013 Jul;169(1):160-3. doi: 10.1111/bjd.12291.

PMID:
23464620
[PubMed - indexed for MEDLINE]
19.

Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.

Hoshimoto S, Faries MB, Morton DL, Shingai T, Kuo C, Wang HJ, Elashoff R, Mozzillo N, Kelley MC, Thompson JF, Lee JE, Hoon DS.

Ann Surg. 2012 Feb;255(2):357-62. doi: 10.1097/SLA.0b013e3182380f56.

PMID:
22202581
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

High throughput mass spectrometry-based mutation profiling of primary uveal melanoma.

Daniels AB, Lee JE, MacConaill LE, Palescandolo E, Van Hummelen P, Adams SM, DeAngelis MM, Hahn WC, Gragoudas ES, Harbour JW, Garraway LA, Kim IK.

Invest Ophthalmol Vis Sci. 2012 Oct 9;53(11):6991-6. doi: 10.1167/iovs.12-10427.

PMID:
22977135
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk